APA (7th ed.) Citation

Afzal, O., Altharawi, A., Alqahtani, S. M., Alossaimi, M. A., Aldakhil, T., Altamimi, A. S. A., . . . Alamri, M. A. (2025). Anticancer potential of novel benzothiazolyl piperidine-3-carboxamide derivatives as CDKs and VEGFR2 multi-target kinase inhibitors. Journal of Computer-Aided Molecular Design: Incorporating Perspectives in Drug Discovery and Design, 39(1), . https://doi.org/10.1007/s10822-025-00599-z

Chicago Style (17th ed.) Citation

Afzal, Obaid, Ali Altharawi, Safar M. Alqahtani, Manal A. Alossaimi, Taibah Aldakhil, Abdulmalik S. A. Altamimi, Alhumaidi Alabbas, and Mubarak A. Alamri. "Anticancer Potential of Novel Benzothiazolyl Piperidine-3-carboxamide Derivatives as CDKs and VEGFR2 Multi-target Kinase Inhibitors." Journal of Computer-Aided Molecular Design: Incorporating Perspectives in Drug Discovery and Design 39, no. 1 (2025). https://doi.org/10.1007/s10822-025-00599-z.

MLA (9th ed.) Citation

Afzal, Obaid, et al. "Anticancer Potential of Novel Benzothiazolyl Piperidine-3-carboxamide Derivatives as CDKs and VEGFR2 Multi-target Kinase Inhibitors." Journal of Computer-Aided Molecular Design: Incorporating Perspectives in Drug Discovery and Design, vol. 39, no. 1, 2025, https://doi.org/10.1007/s10822-025-00599-z.